Stephan Christgau

Président chez Venture Cup Foundation

Profil

Stephan Christgau currently works at Venture Cup Foundation, as Chairman, Octarine Bio ApS, as Chairman from 2020, Life Science Legal ApS, as Director, IO Biotech ApS, as Director, Scenic Biotech BV, as Non-Executive Director, Eir Ventures Danmark ApS, as Managing Partner from 2020, and Eir Ventures Partners AB, as General Partner from 2020.
Dr. Christgau also formerly worked at Thrombologic ApS, as Chairman, PCOVERY ApS, as Chairman, Organon R&D Finland Oy, as Chairman from 2013 to 2020, EpiTherapeutics ApS, as Director, Inagen ApS, as Director, Aros Pharma ApS, as Director, Adenium Biotech ApS, as Director, Acesion Pharma ApS, as Director, Galecto Biotech ApS, as Director, Lysogene SA, as Executive Director, NMD Pharma A, as Director, HepaRegeniX GmbH, as Director, AFYX Therapeutics AS, as Director, Novo Holdings A, as Investment Director from 2017 to 2019, Damora Therapeutics, Inc., as Director from 2020 to 2021, Novo Nordisk A, as Research Scientist, Osteologix, Inc., as Chief Operating Officer & Secretary, Osteometer Biotech AS, as Senior Research Scientist, Osteologix Holdings Plc, as Chief Operating Officer & Executive Vice President, Immunodiagnostic Systems Nordic A, as Senior Research Scientist, and Novo Seeds, as Partner from 2007 to 2019.
Dr. Christgau received his doctorate degree from The University of California, San Francisco and graduate degree from Technical University of Denmark.

Postes actifs de Stephan Christgau

Sociétés	Poste	Début
IO Biotech ApS	Directeur/Membre du Conseil	-
Venture Cup Foundation	Président	-
Octarine Bio IVS	Président	30/06/2020
Eir Ventures Danmark ApS	Private Equity Investor	01/07/2020
iSD Immunotech ApS	Directeur/Membre du Conseil	-
Scenic Biotech BV	Directeur/Membre du Conseil	-
Eir Ventures Partners AB	Private Equity Investor	01/01/2020

Anciens postes connus de Stephan Christgau

Sociétés	Poste	Fin
DAMORA THERAPEUTICS, INC.	Directeur/Membre du Conseil	26/05/2021
Forendo Pharma Oy	Président	01/07/2020
░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░	░░░░░░░░░ ░░ ░░░░ ░░░ ░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░░ ░░░	░░░░░░░░░░	░░░░░░░░░░